Short answer
Omada Health, Inc. (OMDA) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Election of Directors or Officers). Q2 2026 results for three months ended June 30, 2026.
Omada Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results for three months ended June 30, 2026
- Press release issued August 6, 2026
- Detailed financial results furnished in Exhibit 99.1 for investor review
Item 5.02 · Departure/Election of Directors or Officers
- Jeryl Hilleman appointed Lead Independent Director effective on the Leadership Transition’s effective date
- Hilleman remains Board Chair through the Transition Date, providing governance continuity
- No compensation changes approved yet in connection with the Leadership Transition
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Omada Health, Inc. 8-K filings
Get the next OMDA 8-K as it lands
Follow OMDA for push alerts, or ask the research agent what this filing means.